195 related articles for article (PubMed ID: 32229698)
1. Striatin heterozygous mice are more sensitive to aldosterone-induced injury.
Garza AE; Trefts E; Katayama Rangel IA; Brooks D; Baudrand R; Moize B; Romero JR; Ranjit S; Treesaranuwattana T; Yao TM; Adler GK; Pojoga LH; Williams GH
J Endocrinol; 2020 Jun; 245(3):439-450. PubMed ID: 32229698
[TBL] [Abstract][Full Text] [Related]
2. Critical Role of Striatin in Blood Pressure and Vascular Responses to Dietary Sodium Intake.
Garza AE; Pojoga LH; Moize B; Hafiz WM; Opsasnick LA; Siddiqui WT; Horenstein M; Adler GK; Williams GH; Khalil RA
Hypertension; 2015 Sep; 66(3):674-80. PubMed ID: 26169051
[TBL] [Abstract][Full Text] [Related]
3. Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.
Pojoga LH; Yao TM; Opsasnick LA; Siddiqui WT; Reslan OM; Adler GK; Williams GH; Khalil RA
J Pharmacol Exp Ther; 2015 Oct; 355(1):32-47. PubMed ID: 26183312
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone Rapidly Enhances Levels of the Striatin and Caveolin-1 Proteins in Rat Kidney: The Role of the Mineralocorticoid Receptor.
Inthachart K; Manotham K; Eiam-Ong S; Eiam-Ong S
Endocrinol Metab (Seoul); 2019 Sep; 34(3):291-301. PubMed ID: 31565882
[TBL] [Abstract][Full Text] [Related]
5. Striatin genotype-based, mineralocorticoid receptor antagonist-driven clinical trial: study rationale and design.
Stone IB; Green JAEM; Koefoed AW; Hornik ES; Williams JS; Adler GK; Williams GH
Pharmacogenet Genomics; 2021 Jun; 31(4):83-88. PubMed ID: 33904521
[TBL] [Abstract][Full Text] [Related]
6. Role of Nongenomic Signaling Pathways Activated by Aldosterone During Cardiac Reperfusion Injury.
Ashton AW; Le TY; Gomez-Sanchez CE; Morel-Kopp MC; McWhinney B; Hudson A; Mihailidou AS
Mol Endocrinol; 2015 Aug; 29(8):1144-55. PubMed ID: 26121234
[TBL] [Abstract][Full Text] [Related]
7. Activation of the mineralocorticoid receptor increases striatin levels.
Pojoga LH; Coutinho P; Rivera A; Yao TM; Maldonado ER; Youte R; Adler GK; Williams J; Turchin A; Williams GH; Romero JR
Am J Hypertens; 2012 Feb; 25(2):243-9. PubMed ID: 22089104
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone's rapid, nongenomic effects are mediated by striatin: a modulator of aldosterone's effect on estrogen action.
Coutinho P; Vega C; Pojoga LH; Rivera A; Prado GN; Yao TM; Adler G; Torres-Grajales M; Maldonado ER; Ramos-Rivera A; Williams JS; Williams G; Romero JR
Endocrinology; 2014 Jun; 155(6):2233-43. PubMed ID: 24654783
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Thrombotic Responses Are Associated With Striatin Deficiency and Aldosterone.
Gromotowicz-Poplawska A; Flaumenhaft R; Gholami SK; Merrill-Skoloff G; Chabielska E; Williams GH; Romero JR
J Am Heart Assoc; 2021 Nov; 10(22):e022975. PubMed ID: 34729990
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone's mechanism of action: roles of lysine-specific demethylase 1, caveolin and striatin.
Baudrand R; Pojoga LH; Romero JR; Williams GH
Curr Opin Nephrol Hypertens; 2014 Jan; 23(1):32-7. PubMed ID: 24275769
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
Arai K; Homma T; Morikawa Y; Ubukata N; Tsuruoka H; Aoki K; Ishikawa H; Mizuno M; Sada T
Eur J Pharmacol; 2015 Aug; 761():226-34. PubMed ID: 26073023
[TBL] [Abstract][Full Text] [Related]
12. Variants in striatin gene are associated with salt-sensitive blood pressure in mice and humans.
Garza AE; Rariy CM; Sun B; Williams J; Lasky-Su J; Baudrand R; Yao T; Moize B; Hafiz WM; Romero JR; Adler GK; Ferri C; Hopkins PN; Pojoga LH; Williams GH
Hypertension; 2015 Jan; 65(1):211-217. PubMed ID: 25368024
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid and angiotensin receptor antagonism during hyperaldosteronemia.
Mihailidou AS; Mardini M; Funder JW; Raison M
Hypertension; 2002 Aug; 40(2):124-9. PubMed ID: 12154101
[TBL] [Abstract][Full Text] [Related]
14. CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats.
Arai K; Tsuruoka H; Homma T
Eur J Pharmacol; 2015 Dec; 769():266-73. PubMed ID: 26607463
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone Antagonism Is More Effective at Reducing Blood Pressure and Excessive Renal ENaC Activity in AngII-Infused Female Rats Than in Males.
Buncha V; Cherezova A; Alexander S; Baranovskaya I; Coleman KA; Cherian-Shaw M; Brands MW; Sullivan JC; O'Connor PM; Mamenko M
Hypertension; 2023 Oct; 80(10):2196-2208. PubMed ID: 37593894
[TBL] [Abstract][Full Text] [Related]
16. Effects of Mineralocorticoid Receptor Blockade and Statins on Kidney Injury Marker 1 (KIM-1) in Female Rats Receiving L-NAME and Angiotensin II.
Huang J; Caliskan Guzelce E; Gholami SK; Gawelek KL; Mitchell RN; Pojoga LH; Romero JR; Williams GH; Adler GK
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047470
[TBL] [Abstract][Full Text] [Related]
17. Effect of a novel nonsteroidal selective mineralocorticoid receptor antagonist, esaxerenone (CS-3150), on blood pressure and renal injury in high salt-treated type 2 diabetic mice.
Bhuiyan AS; Rafiq K; Kobara H; Masaki T; Nakano D; Nishiyama A
Hypertens Res; 2019 Jun; 42(6):892-902. PubMed ID: 30664703
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
Oestreicher EM; Martinez-Vasquez D; Stone JR; Jonasson L; Roubsanthisuk W; Mukasa K; Adler GK
Circulation; 2003 Nov; 108(20):2517-23. PubMed ID: 14581407
[TBL] [Abstract][Full Text] [Related]
19. Lysine-Specific Demethylase-1 Deficiency Increases Agonist Signaling Via the Mineralocorticoid Receptor.
Treesaranuwattana T; Wong KYH; Brooks DL; Tay CS; Williams GH; Williams JS; Pojoga LH
Hypertension; 2020 Apr; 75(4):1045-1053. PubMed ID: 32160100
[TBL] [Abstract][Full Text] [Related]
20. Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.
Martinez DV; Rocha R; Matsumura M; Oestreicher E; Ochoa-Maya M; Roubsanthisuk W; Williams GH; Adler GK
Hypertension; 2002 Feb; 39(2 Pt 2):614-8. PubMed ID: 11882618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
